Fund Venture Atlas VII Net Worth & Insider Trades

Fund Venture Atlas VII Arca Biopharma, Inc

As of March 31, 2010

What is Fund Venture Atlas VII's Net Worth?

The current estimated net worth of Arca Biopharma, Inc's Fund Venture Atlas VII is estimated to be about $4.14M . Fund Venture Atlas VII owns about 1,337,612 units of Arca Biopharma, Inc common stock. Recently at Arca Biopharma, Inc, Fund Venture Atlas VII has sold an estimated value of $1.06M worth.

What is Fund Venture Atlas VII's Past Insider Trading?

Fund Venture Atlas VII's largest sale order was 140,000 units , worth over $1.06M on March 31, 2010. In total, Fund Venture Atlas VII has made about 1 transaction recently at Arca Biopharma, Inc. Fund Venture Atlas VII usually trades in March, with the busiest year in 2010.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Fund Venture Atlas VII's' Mailing Address?

  • Mailing address is 46 Wareham Street, Floor 3 Boston MA 02118 MA

Arca Biopharma, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Michael R. Bristow 2020 $286,083 $619,976 $144,000 $11,528 $1,061,587
Michael R. Bristow 2019 $284,328 - - $11,823 $296,151
Thomas A. Keuer 2020 $284,937 $228,412 $98,000 $19,675 $631,024
Thomas A. Keuer 2019 $283,189 - - $20,833 $304,022
Christopher D. Ozeroff 2020 $279,617 $179,467 $84,000 $12,764 $555,848
Christopher D. Ozeroff 2019 $277,901 - - $12,256 $290,157
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/907654/000156459021019817/abio-def14a_20210610.htm

What are Arca Biopharma, Inc's Past Insider Trades?

Arca Biopharma, Inc's most recent insider trade came on May 25, 2022 by Funicular Fund Lp and Jacob Maweaver who bought 85,262 units worth $197.4K . In the last 13 years, insiders at Arca Biopharma, Inc have sold an estimated value of $15.26M and bought an estimated value of $5.56M worth of shares. Insider trading is most common in February, with the busiest year in 2016. The most active traders at the company are Michael Bristow, Pres. & Chief Executive Offic,  David Christopher Ozeroff, S.V.P.,  and Robert Conway, Director .

ARCA biopharma, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1